SCHARR HEDS at ISPOR Europe 2023
SCHARR HEDS will be joining global healthcare leaders at the ISPOR Annual European Congress, the leading global conference in Europe for HEOR, 12 - 15 November in Copenhagen, Denmark, for discussion and dissemination of the latest trends in healthcare
Come and meet us on Stand C2-021 in Hall E
Schedule a meeting with us using the link below or connect with our social media channels
See our programme of events below, or for more information about our Knowledge Exchange work, take a look at our dedicated webpages
We are excited to launch the ‘Sheffield Evaluation Hub’ focussed on the analysis of Real-World Data (RWD) to generate Real-World Evidence (RWE) to inform health technology assessment (HTA) processes. Dr Matthew Franklin will be available to discuss our expertise in a range of methodologies for RWE generation.
Monday 13 November
10:15 - 11:15: W2: Estimands in Clinical Trials and HEOR: Applications and Considerations
Nick Latimer, discussant on 'in person' panel. Concurrent Breakout Session 1 (W2)
10:15 - 11:15: 105: The Role of Patient Preferences in Economic Evaluations: Barriers and Opportunities for a Patient-Based QALY
Paul Schneider, Moderator (on behalf of Valorem Health) and Ben van Hout, Panellist on 'in person' panel. Concurrent Breakout Session 1 (105)
Helen Bell Gorrod, poster presenter, co-author Nick Latimer. Poster Session 1
11:45 - 12:45: Are We Patient-Centered Yet? Patient Engagement and Patient-Centered Research in HEOR
Jill Carlton, speaker on ISPOR Forum.
Donna Rowen, moderator on Member Group Meeting
15:30 - 18:30: The Hazards of Applying Hazard Ratios to Accelerated Failure Time Models: A Simulation Study
Nick Latimer poster co-author. Poster Session 2 (Discussion Period 16:00 - 17:00)
Matt Franklin poster presenter, co-author Nick Latimer. Poster Session 2 (Discussion Period 16:00 - 17:00)
17:00 - 18:00: Measuring Health Related Quality of Life in Pediatric Life Limiting Progressive Diseases. Whose Perspective Are We Measuring?
Jill Carlton, panellist on 'in person' panel. Concurrent Breakout Session 3
Tuesday 14 November
Donna Rowen, poster presenter, co-authors Mukuria C, Cooper S, Bray N, Carlton J, Longworth L, Meads D, Oluboyede Y, O'Neill C, Yang Y. Poster Session 3
13:45 - 14:45: Early Endpoints in Oncology: Increasingly Common in Clinical Trials Yet Frequently Challenged in Health Technology Appraisals (HTAs)
Nick Latimer, panellist on 'in person' panel. Concurrent Breakout Session 5
13:45- 14:45: Incorporating External Evidence into Extrapolations: A Debate on the Trade-Offs between Complexity and Simplicity
Ash Bullement (on behalf of Delta Hat), panellist on 'in person' panel. Concurrent Breakout Session 5
15:15- 16:15: Implementing Novel Value Elements and Methods in Health Technology Assessment: The Case of Advanced Therapies (239)
Allan Wailoo, speaker on 'in person' forum. ISPOR Forum
15:30- 18:30: Treatment Effect Waning in Immuno-Oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence
Nick Latimer, poster co-author. Poster Session 4
Wednesday 15 November
09:00 - 11:30: A Novel Unanchored Simulated Treatment Comparison Approach for Time-to-Event Data
Sarah Ren , poster presenter. Poster Session 5 (Discussion Period 09:00 - 10:00)
09:00 - 11:30: Accounting for Study Heterogeneity When Modelling the Multi-State Natural History of Rare Diseases (MSR147)
Nick Latimer , poster presenter. Poster Session 5 (Discussion Period 09:00 - 10:00)
Nick Latimer , poster presenter. Poster Session 5 (Discussion Period 09:00 - 10:00)
10:30 - 10:45: P51: Testing a Survival Extrapolation Algorithm for Cancer Immunotherapies: Pass or Fail?
Nick Latimer, podium presentation. Podium Session: Challenges in Modelling Oncology Outcomes
Our Industry Partner
Find out more about our Industry Partner below
